BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 30, 2016
View Archived Issues
EILV as an affordable and efficient alphavirus vaccine platform against chikungunya fever
Read More
SAR-408701 shows acceptable safety profile in patients with solid tumors
Read More
ADCT-502 shows promise for low HER2-expressing solid cancers
Read More
Phase II results from the LUME-MESO trial of nintedanib in mesothelioma
Read More
Exosomal miRNAs show potential as rapid and noninvasive biomarkers of NSCLC
Read More
Facio identifies variety of compounds with ability to repress production of DUX4 protein
Read More
Prima BioMed announces interim data from first-in-human combination phase I study of IMP-321
Read More
FDA issues complete response letter regarding Cempra's NDAs for solithromycin
Read More
Bavarian Nordic commences study of CV-301 plus nivolumab in NSCLC
Read More
Pivotal study of BioCardia's CardiAMP in heart failure begins
Read More
Phase II results for F-17464 in patients with acutely exacerbated schizophrenia
Read More
Medical Prognosis Institute and Oncology Venture sign series of agreements
Read More
FDA issues refusal to file letter for Innocoll's Xaracoll
Read More
Intarcia enters relationship with Bill & Melinda Gates Foundation for HIV prophylactic therapy
Read More
FDA grants orphan drug designation to MacroGenics' CD123 x CD3 DART protein for AML
Read More
U.S. orphan drug designation for ganaxolone in fragile X syndrome
Read More
FDA awards orphan drug designation to Yisheng's rabies vaccine
Read More
Keytruda granted U.S. orphan drug designation for Merkel cell carcinoma
Read More
East China University of Science and Technology patents HER1 inhibitors
Read More
Femtogenix discloses anticancer agents
Read More
FDA grants orphan drug designation to silmitasertib for cholangiocarcinoma
Read More
Hangzhou Innogate Pharma describes SYK/HDAC inhibitors
Read More
Basilea Pharmaceutica develops antibacterial activity enhancers
Read More
TetraLogic completes sale of two programs to Medivir
Read More
Merck & Co. presents adenosine A2A receptor antagonists
Read More